Sanofi
SNY
NASDAQ·Healthcare·Drug Manufacturers - General·Mkt cap $106.8B
$44.33
▼ -0.31%
P/E
86.33
Mkt Cap
$106.8B
52-Wk Range
$40.89–$52.68
52-Week Range
$40.89 - $52.68
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 10.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.3).
Growth
Stable outlook
Value
Deep value opportunity - significant discount to sector peers
Momentum
Stable
+5.0% over 3m
Quality
Excellent
Excellent business quality
Dividend
High yield
10.80% yield
Smart-money signal
Who's buying SNY right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 23, 2026
JUL 30, 2026
Reported EPS of $1.21 vs $1.10 consensus (+10.0% surprise). Revenue of $14.1B vs $13.0B expected (+8.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+10.0%
Revenue trend · last 8Q
—
—
—
-6%
-7%
+60%
+6%
+15%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$14.2B
$7.6B
$10.6B
$10.7B
$13.2B
$12.2B
$11.2B
$14.4B
Margins · last 8Q
Gross
—
Operating
—
Profit
2.8%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How SNY stacks vs Drug Manufacturers - General
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.